Cabenuva and Social Security Disability Benefits
TELL US WHAT HAPPENED SO WE CAN HELP. FREE CONSULTATION
Contact Us About Your Case
FREE Consultation Today.
Cabenuva and Social Security Disability Benefits
Cabenuva is a long-acting injectable HIV treatment that combines:
- cabotegravir
- rilpivirine
Unlike daily oral HIV medications, Cabenuva is given as two intramuscular injections on a monthly or every-two-month schedule, depending on the treatment plan.
Current FDA labeling identifies Cabenuva as a complete regimen for eligible adults and adolescents with HIV-1 who are already virologically suppressed on a stable antiretroviral regimen and who have no history of treatment failure or known or suspected resistance to cabotegravir or rilpivirine.
Taking Cabenuva does not automatically qualify someone for Social Security Disability benefits. However, it does help prove the severity of the underlying condition.
Many people receiving Cabenuva have well-controlled HIV and continue working without significant limitations. Others continue to experience:
- severe fatigue
- neuropathy
- cognitive problems
- recurrent infections
- gastrointestinal symptoms
- depression
- treatment side effects
- injection-related symptoms
- liver problems
- excessive medical appointments or absences
For Social Security, the important question is whether HIV, its complications, and treatment effects prevent sustained full-time work.
What Is Cabenuva?
Cabenuva is a two-drug long-acting antiretroviral regimen.
It contains:
- cabotegravir, an integrase strand transfer inhibitor
- rilpivirine, a non-nucleoside reverse transcriptase inhibitor
The medications are given as separate gluteal intramuscular injections during the same treatment visit.
Current FDA labeling provides both:
- monthly dosing
- every-two-month dosing
An oral lead-in may be considered before injections to assess tolerability, but it is not required in every case.
NIH guidelines continue to recognize long-acting cabotegravir/rilpivirine as an option for selected people with HIV who are virologically suppressed and engaged in care.
Can Taking Cabenuva Qualify You for Social Security Disability?
Not by itself.
A Cabenuva prescription primarily shows that a person is receiving treatment for HIV.
A stronger disability claim may exist when HIV or treatment-related problems continue to cause:
- severe fatigue
- frequent infections
- neuropathy
- cognitive impairment
- dizziness
- persistent pain
- depressive symptoms
- liver complications
- frequent absences
- inability to complete full shifts
The strongest claims connect these symptoms to specific workplace limitations.
Cabenuva and HIV Disability Claims
Adult HIV infection is evaluated under Social Security Blue Book Listing 14.11.
A person may qualify through:
- certain serious HIV-related conditions
- very low CD4 counts
- low CD4 measurements combined with severe anemia or weight loss
- repeated HIV-related hospitalizations
- repeated HIV manifestations causing marked functional limitations
A person who does not meet Listing 14.11 may still qualify through residual functional capacity if HIV and related conditions prevent sustained work.
Cabenuva and Viral Suppression
Cabenuva is generally used after a person has already achieved viral suppression on another antiretroviral regimen.
That creates an important disability issue.
An undetectable viral load does not automatically prove that someone can work full time.
A person may continue to have:
- neuropathy
- chronic fatigue
- cognitive impairment
- prior neurological injury
- chronic pain
- liver disease
- depression
- complications from earlier infections
- other serious medical conditions
Social Security should evaluate actual functioning, not simply viral-load results.
Cabenuva Injection-Site Reactions
Injection-site reactions are the most common adverse reactions associated with Cabenuva.
Symptoms may include:
- pain
- tenderness
- swelling
- firmness
- redness
- nodules
- discomfort with sitting or movement
For many patients, injection-site symptoms are mild and temporary.
For disability purposes, they become more important when they are:
- severe
- persistent
- recurrent
- disruptive to walking or sitting
- significant enough to cause missed work
A person receiving injections every month or every two months may also need recurring medical visits that affect scheduling and attendance.
Cabenuva and Post-Injection Reactions
Current prescribing information warns about serious post-injection reactions associated with rilpivirine injections.
Reported symptoms have included combinations of:
- difficulty breathing
- agitation
- abdominal cramping
- flushing
- sweating
- oral numbness
- changes in blood pressure
- dizziness
These reactions have generally occurred within minutes after injection.
Because of this risk, patients are monitored after administration as clinically appropriate.
For Social Security purposes, a rare post-injection event does not establish disability by itself. Repeated or severe reactions, however, may contribute to treatment burden and work absences.
Cabenuva and Fatigue
Fatigue is among the more common adverse reactions reported with Cabenuva.
Fatigue may also result from:
- HIV itself
- anemia
- chronic infection
- depression
- poor sleep
- chronic pain
- other medical conditions
Work-related effects may include:
- reduced pace
- poor concentration
- need for additional breaks
- reduced stamina
- inability to complete full shifts
- difficulty working consecutive days
Cabenuva and Headaches
Headache is also among the commonly reported Cabenuva adverse reactions.
Frequent or severe headaches may interfere with:
- concentration
- computer use
- pace
- attendance
- tolerance for light or noise
- completion of tasks
The disability significance depends on frequency, duration, severity, and response to treatment.
Cabenuva and Dizziness
Dizziness is another reported adverse reaction with Cabenuva.
Dizziness may affect:
- standing
- walking
- driving
- balance
- stairs
- ladders
- machinery
- concentration
If a person also has HIV-related neuropathy or weakness, dizziness may create additional safety concerns.
Cabenuva and Musculoskeletal Pain
Musculoskeletal pain is among the common adverse reactions reported with Cabenuva.
Pain may interfere with:
- sitting
- standing
- walking
- lifting
- sleep
- concentration
- pace
When injection-site pain and musculoskeletal pain occur together, a person may temporarily have more difficulty with mobility or prolonged sitting.
Cabenuva and Sleep Problems
Sleep disorders are also among the more commonly reported Cabenuva adverse reactions.
Poor sleep may result in:
- daytime fatigue
- irritability
- poor concentration
- reduced pace
- slower thinking
- difficulty maintaining reliable attendance
For a disability claim, the focus should be on the functional effect of persistent sleep disturbance.
Cabenuva and Depression
Current Cabenuva labeling warns that depressive disorders have been reported and recommends prompt evaluation of depressive symptoms.
Depression may affect work through:
- low motivation
- poor concentration
- social withdrawal
- fatigue
- reduced pace
- difficulty handling stress
- excessive absences
A person may also have depression independent of Cabenuva.
Social Security should consider all medically documented mental and physical impairments together.
Cabenuva and Liver Problems
Current prescribing information warns that hepatotoxicity has been reported with cabotegravir- or rilpivirine-containing regimens and recommends monitoring liver chemistries.
Liver problems may contribute to:
- fatigue
- weakness
- nausea
- reduced stamina
- additional testing
- treatment changes
- hospitalization in severe cases
A theoretical risk alone does not establish disability. Actual liver impairment must be medically documented and functionally significant.
Cabenuva and Hypersensitivity Reactions
Serious hypersensitivity reactions have been reported with cabotegravir- and rilpivirine-containing regimens.
Current labeling identifies severe reactions including:
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- DRESS syndrome
and instructs clinicians to discontinue treatment if significant hypersensitivity symptoms develop.
These reactions are uncommon but potentially serious.
If they occur, they may result in:
- emergency treatment
- hospitalization
- medication changes
- prolonged recovery
- missed work
Cabenuva and Missed Injections
One of the most distinctive issues with Cabenuva is the importance of maintaining the injection schedule.
Because it is long-acting, missing injections without proper replacement treatment can create a risk of:
- inadequate drug concentrations
- loss of viral suppression
- development of drug resistance
The FDA label provides specific procedures for planned and unplanned missed injections.
This may become relevant when a person has difficulty attending treatment because of:
- transportation problems
- cognitive impairment
- severe illness
- hospitalization
- mental health symptoms
- unstable functioning
For disability purposes, treatment adherence difficulties should be evaluated in context rather than assumed to reflect unwillingness to follow medical advice.
Cabenuva’s Long-Acting Effects
Cabotegravir and rilpivirine can remain in the body for 12 months or longer after the last Cabenuva injection.
Because of this prolonged drug exposure, current labeling stresses the importance of starting another fully suppressive HIV regimen within the required time after stopping Cabenuva.
This makes treatment transitions more complex than simply stopping a daily tablet.
Cabenuva and Drug Interactions
Cabenuva has clinically important drug interactions.
Certain medications can significantly decrease cabotegravir or rilpivirine levels and increase the risk of treatment failure or resistance.
Current labeling also advises caution with medications associated with risk of torsades de pointes.
Drug interactions may become relevant to a disability claim when they cause:
- medication changes
- increased monitoring
- side effects
- fewer treatment options
- difficulty maintaining stable therapy
Cabenuva and Peripheral Neuropathy
Cabenuva is not necessarily the cause of neurological symptoms in someone living with HIV.
HIV itself may cause peripheral neuropathy, and neuropathy may persist even after viral suppression.
Symptoms may include:
- burning pain
- numbness
- tingling
- weakness
- balance problems
- difficulty walking
- hand dysfunction
Foot neuropathy may limit standing and walking.
Hand neuropathy may interfere with:
- typing
- writing
- gripping
- handling
- fingering
Cabenuva and Cognitive Problems
Some people living with HIV continue to experience neurocognitive symptoms despite effective antiretroviral treatment.
Possible symptoms include:
- memory problems
- poor concentration
- slowed thinking
- difficulty organizing tasks
- reduced mental stamina
- trouble learning new information
At work, these limitations may cause:
- mistakes
- missed deadlines
- forgotten instructions
- reduced pace
- excessive off-task time
- difficulty multitasking
Can You Work While Taking Cabenuva?
Yes.
Many people receiving Cabenuva work without significant limitations.
The medication itself does not establish disability.
The more important questions are:
- Is HIV well controlled?
- Are significant complications still present?
- Are injections or side effects causing functional problems?
- Is fatigue severe?
- Are cognitive problems present?
- Is attendance reliable?
- Can the person complete a normal workday?
Two people receiving the same HIV treatment may have very different levels of work capacity.
Can Cabenuva-Related Conditions Prevent Sedentary Work?
Yes.
Sedentary work still requires:
- regular attendance
- sustained concentration
- consistent pace
- prolonged sitting
- some standing and walking
- hand use
- limited unscheduled breaks
- completion of full workdays
Sedentary work may become difficult when:
- injection pain interferes with sitting
- fatigue limits stamina
- dizziness affects safety
- neuropathy affects mobility or hand use
- cognitive problems cause excessive off-task time
- depression affects pace or attendance
- recurrent illness causes excessive absences
Simply being able to sit does not establish the ability to sustain full-time employment.
Cabenuva and Residual Functional Capacity
Residual Functional Capacity, or RFC, describes what a person can still do despite medical limitations.
An HIV claim involving Cabenuva may include restrictions involving:
- sitting
- standing
- walking
- handling
- fingering
- concentration
- pace
- environmental exposure
- additional breaks
- off-task time
- attendance
For example:
- Fatigue may reduce stamina and pace.
- Injection pain may temporarily affect sitting or walking.
- Neuropathy may limit mobility or hand use.
- Cognitive symptoms may limit complex tasks.
- Dizziness may create safety restrictions.
- Depression may affect concentration and attendance.
- Recurrent illness may cause excessive absences.
The RFC should reflect the combined effects of HIV, related conditions, and treatment.
Medical Evidence That May Support a Cabenuva Disability Claim
Helpful evidence may include:
- infectious disease specialist records
- HIV treatment records
- CD4 testing
- viral-load testing
- injection records
- documentation of injection-site reactions
- liver-function testing
- hospitalization records
- infection records
- neuropathy evaluations
- cognitive testing
- psychiatric records
- medication history
- documented treatment side effects
- records of missed work
- provider statements describing functional limitations
The strongest evidence connects medical findings to practical workplace problems.
Documenting Cabenuva Side Effects
Medication effects are more persuasive when documented consistently.
Helpful evidence may include:
- injection-site pain
- fatigue
- headaches
- dizziness
- sleep problems
- nausea
- musculoskeletal pain
- depression
- liver abnormalities
- post-injection reactions
- medication changes
A strong claim explains not simply that a side effect occurs, but how often it happens and how it affects work.
Doctor Statements About Work Limitations
A treating provider may be able to address:
- fatigue
- neuropathy
- walking tolerance
- sitting tolerance
- cognitive problems
- dizziness
- injection-related limitations
- medication side effects
- need for breaks
- expected absences
- concentration
- ability to complete a full workday
Specific functional opinions are generally more useful than simply stating that a patient is “disabled.”
Signs Cabenuva May Be Relevant to Your Disability Claim
Cabenuva treatment may be relevant when HIV or treatment-related problems continue to cause:
- severe fatigue
- recurrent infections
- persistent injection-related pain
- neuropathy
- cognitive impairment
- dizziness
- depression
- liver complications
- frequent treatment visits
- excessive absences
- inability to complete full shifts
When these limitations are persistent and medically documented, the claim may be stronger.
Common Mistakes in Cabenuva Disability Claims
Common problems include:
- relying on Cabenuva treatment itself as proof of disability
- assuming HIV automatically proves disability
- assuming viral suppression automatically proves ability to work
- failing to document injection reactions
- ignoring fatigue
- overlooking neuropathy
- failing to document cognitive problems
- ignoring depression or liver complications
- failing to explain treatment-related absences
- failing to connect symptoms to specific RFC limitations
A strong claim focuses on actual functioning despite treatment.
When to Speak With a Social Security Disability Lawyer
Many people seek legal help when:
- their disability claim has been denied
- HIV complications continue despite Cabenuva
- fatigue prevents full-time work
- neuropathy affects mobility or hand use
- injection reactions interfere with functioning
- cognitive symptoms affect work
- depression or dizziness creates additional limitations
- frequent treatment or illness causes excessive absences
- Social Security assumes viral suppression means the person can work
Our social security disability attorneys can help evaluate how HIV, Cabenuva treatment, medical complications, treatment burden, and RFC limitations fit into the overall claim.
FAQs: Cabenuva and Social Security Disability Benefits
Can taking Cabenuva qualify me for Social Security Disability?
Not by itself. Social Security evaluates HIV, related complications, medication effects, and the ability to sustain full-time employment.
What is Cabenuva used to treat?
Cabenuva is a complete two-drug long-acting regimen containing cabotegravir and rilpivirine for eligible people with HIV-1 who are already virologically suppressed and meet the treatment criteria.
Is Cabenuva taken every day?
No. Cabenuva is given by intramuscular injection either monthly or every two months, depending on the prescribed regimen.
What are the most common Cabenuva side effects?
The most common adverse reactions include injection-site reactions, fever, fatigue, headache, musculoskeletal pain, nausea, sleep disorders, dizziness, and rash.
Can Cabenuva cause injection-site pain?
Yes. Injection-site reactions are the most common adverse reactions associated with Cabenuva.
Can Cabenuva cause fatigue or dizziness?
Yes. Both fatigue and dizziness are among the commonly reported adverse reactions.
Can Cabenuva affect depression?
Depressive disorders have been reported with Cabenuva, and current labeling recommends prompt evaluation of depressive symptoms.
Can Cabenuva affect the liver?
Yes. Hepatotoxicity has been reported with cabotegravir- and rilpivirine-containing regimens, and monitoring of liver chemistries is recommended.
What happens if a Cabenuva injection is missed?
Cabenuva has specific procedures for planned and unplanned missed injections. Because the medications remain in the body for a long time, maintaining an appropriate treatment schedule or alternative suppressive therapy is important to avoid loss of viral control and resistance.
Can I qualify for disability if Cabenuva keeps my viral load undetectable?
Potentially. Viral suppression does not automatically establish work capacity. Persistent fatigue, neuropathy, cognitive impairment, depression, liver disease, recurrent infections, treatment effects, or other limitations may still prevent sustained employment.
Can HIV prevent sedentary work?
Yes. Fatigue, neuropathy, cognitive problems, dizziness, depression, treatment effects, recurrent infections, or excessive absences may make even sedentary work unsustainable.
What evidence helps prove a Cabenuva-related disability claim?
Helpful evidence may include infectious disease records, viral-load and CD4 testing, injection records, documented injection reactions, liver testing, neuropathy records, cognitive or psychiatric evaluations, medication history, and provider statements describing specific work limitations.
What should I do if HIV prevents me from working despite Cabenuva?
You may want to speak with a Social Security Disability attorney to evaluate whether your HIV meets Listing 14.11 or whether your combined symptoms, treatment burden, and RFC limitations prevent sustained employment.
Contact MLF Legal for a Free Disability Case Evaluation
If HIV, chronic fatigue, neuropathy, cognitive problems, recurrent infections, Cabenuva side effects, or another medical condition prevents you from working, you may qualify for Social Security Disability benefits.
MLF Legal represents disability applicants nationwide. Based in Dallas, Texas, we help individuals across the country pursue disability benefits.
Our social security lawyers can review your situation for free and explain your options.
📞 Call MLF Legal at 214-357-1782 to request a free consultation.
Next Steps:
1st Sign up For a Free One-on-One Disability Case Evaluation
Contact us today to schedule your personalized one-on-one free phone consultation with one of our dedicated legal professionals. Our experienced social security lawyers are here to provide the expert legal guidance and support you need throughout the entire process of your case.
We understand the complexities involved in social security disability claims and are committed to helping you achieve the best possible outcome. Don’t hesitate to reach out and take the first step toward securing the justice you deserve.
2nd Download Free E-Books
Social Security Disability
Navigating the Social Security Disability Benefits process can be complex, but understanding the key steps can help. From gathering medical records to completing the application, this process ensures eligible individuals receive the support they need. Seeking guidance from experts can simplify the journey and increase the chances of a successful outcome.
Call MLF Legal today
214-357-1782
Fill out our online form
for a free consultation.
We only get paid if we win your case.